ProRhythm is committed to becoming the worldwide leader in generating and targeting therapeutic ultrasound. ProRhythm will apply this know-how to make therapeutic procedures less invasive for the patient’s benefit.

Utilizing High Intensity Focused Ultrasound (HIFU), ProRhythm will be the worldwide leader in developing a fast, safe and effective catheter-based procedure to treat the 8.2 million people who suffer from Atrial Fibrillation.